<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"><head>

<title>Drug Assay Numbers, All Over the Place. In the Pipeline: </title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta name="description" content="">
<meta name="ICBM" content="42.341665, -71.078200">
<meta name="DC.title" content="Corante: Boston">
<!-- http://geourl.org/news/2005/02/25/launch.html -->

<!-- sitewide CSS -->

<link rel="stylesheet" href="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/blogs.css" type="text/css">
<link rel="stylesheet" href="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/local.css" type="text/css">

<link rel="shortcut icon" href="http://www.corante.com/favicon.ico" type="image/ico">

<!-- points to Feedburner.com -->
<link rel="alternate" type="application/rss+xml" title="RSS" href="http://pipeline.corante.com/index.xml">

<!-- Site Javascript  CONSOLIDATE -->
<script src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/site_wide.js" language="javascript" type="text/javascript"></script>
<script src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/obfuscator.js" language="javascript" type="text/javascript"></script>

<script type="text/javascript">
var __MTTBLINK__;
var __MTTBID__;
function obfuscator(coded, key, mode, path, hidden) {
	shift = coded.length;
	link = "";
	
	for(i=0;i<coded.length;i++) {
		if (key.indexOf(coded.charAt(i))==-1) {
			ltr = coded.charAt(i);link+=(ltr);
		} else {
			ltr = (key.indexOf(coded.charAt(i)) - shift + key.length) % key.length;
			link += (key.charAt(ltr));
		}
	}
	if(mode == 'hidden_input') {
		document.write('<input type="hidden" name="CCode" value="' + link + '" />');
	} else if(mode == '__MTTBLINK__') {
		__MTTBLINK__ = path + link;
		if(hidden) return;
		document.write(link);
	} else if(mode == '__MTTBID__') {
		__MTTBID__ = link;
		if(hidden) return;
		document.write(link);
	}
}
</script>

<!-- RSS -->
<link rel="alternate" type="application/rss+xml" title="RSS" href="http://pipeline.corante.com/index.xml">
<link rel="alternate" type="application/atom+xml" title="Atom" href="http://pipeline.corante.com/atom.xml">
<link rel="EditURI" type="application/rsd+xml" title="RSD" href="http://pipeline.corante.com/rsd.xml">

<script type="text/javascript" src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/mt-site.js"></script>

</head>
<body>

<div id="aboutlinks">
<a href="http://www.corante.com/about.php">About Us</a> | <a href="http://www.corante.com/rss.php">RSS</a> | <a href="http://www.corante.com/adinfo.php">Advertise</a> | <a href="http://www.corante.com/contact.php">Contact Us</a>
</div>
<h1><a href="http://www.corante.com/"><img src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/corante_head_logo2.gif" alt="Corante" height="37" border="0" width="233"></a></h1>

<!-- NAVBAR -->

<table border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr><td class="sitenav" height="25"><a href="http://www.corante.com/">Home</a> &gt; Weblog Columns &gt; <a href="http://pipeline.corante.com/">In the Pipeline</a></td><td class="sitenav" align="right"><form action="#">
<select onchange="javascript:document.location=options[selectedIndex].value;" class="archivemenu">
<option selected="selected" value="#">Weblog columns [select a blog]</option>
<option value="http://corante.corante.com/">[Corante Blog]</option>
<option value="http://betweenlawyers.corante.com/">BETWEEN
LAWYERS: technology + culture + law</option>
<option value="http://brainwaves.corante.com/">BRAIN
WAVES:
neurons, bits  &amp; genes</option>
<option value="http://copyfight.corante.com/">COPYFIGHT: the
politics of intellectual property</option>
<option value="http://goyami.corante.com/">GOYAMI: search engine marketing</option>
<option value="http://ideaflow.corante.com/">IDEAFLOW:
creativity
+ innovation</option>
<option value="http://pipeline.corante.com/">IN THE
PIPELINE: drug
discovery</option>
<option value="http://many.corante.com/">MANY-TO-MANY: social
software</option>
<option value="http://rebuildingmedia.corante.com/">REBUILDING
MEDIA: the economics of media</option>
<option value="http://strange.corante.com/">STRANGE ATTRACTOR:
social media</option>
<option value="http://totalexperience.corante.com/">TOTAL
EXPERIENCE: experience design</option>
</select>
</form></td><td style="background:url(http://www.corante.com/frontpage/crush_corner_etnaroc.gif) top right no-repeat;" width="9" align="right">
</td>
</tr>
<tr>
<td colspan="3">

<!-- SUB NAV/3 COLUMNS -->

<table id="content" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr>
<td valign="top">

<div class="side">
<h5>About this Author</h5>

<img alt="DBL%20Hendrix%20small.png" src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/DBL%2520Hendrix%2520small.png" height="199" width="115">
College chemistry, 1983
<br>
<br>
<img src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/dbl.jpg" alt="Derek Lowe" border="0" width="115">
The 2002 Model
<br>
<br>
<img alt="Dbl%20new%20portrait%20B%26W.png" src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/Dbl%2520new%2520portrait%2520BW.png" height="144" width="115">
After 10 years of blogging. . .
<br>
<br>
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and 
his PhD in organic chemistry from Duke before spending time in Germany 
on a Humboldt Fellowship on his post-doc. He's worked for several major 
pharmaceutical companies since 1989 on drug discovery projects against 
schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. 
To contact Derek email him directly: <a href="mailto:derekb.lowe@gmail.com">derekb.lowe@gmail.com</a>
Twitter: Dereklowe<br>
<br>


<iframe src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/cm.html" scrolling="no" frameborder="0" height="90" width="120"></iframe>
</div>

<div class="side">
Chemistry and Drug Data:
<a href="http://www.drugbank.ca/">Drugbank</a><br>
<a href="http://www.emolecules.com/">Emolecules</a><br>
<a href="http://www.chemspider.com/">ChemSpider</a><br>
<a href="http://lab.chempedia.com/">Chempedia Lab</a><br>
<a href="http://www.syntheticpages.org/">Synthetic Pages</a><br>
<a href="http://www.organic-chemistry.org/">Organic Chemistry Portal</a><br>
<a href="http://pubchem.ncbi.nlm.nih.gov/">PubChem</a><br>
<a href="http://chem.chem.rochester.edu/%7Envd/index.html">Not Voodoo</a><br>
<a href="http://dailymed.nlm.nih.gov/dailymed/about.cfm">DailyMed</a><br>
<a href="http://www.druglib.com/">Druglib</a><br>
<a href="http://clinicaltrials.gov/">Clinicaltrials.gov</a><br>
<br>
Chemistry and Pharma Blogs:
<br>
<a href="http://orgprepdaily.wordpress.com/">Org Prep Daily</a><br>
<a href="http://cenblog.org/the-haystack/">The Haystack</a><br>
<a href="http://kilomentor.com/">Kilomentor</a><br>
<a href="http://anewmerckreviewed.wordpress.com/">A New Merck, Reviewed</a><br>
<a href="http://liberalchemistry.blogspot.com/">Liberal Arts Chemistry</a><br>
<a href="http://cenblog.org/just-another-electron-pusher/">Electron Pusher</a><br>
<a href="http://allthingsmetathesis.com/">All Things Metathesis</a><br>
<a href="http://cenblog.org/">C&amp;E News Blogs</a><br>
<a href="http://luysii.wordpress.com/">Chemiotics II</a><br>
<a href="http://chemicalspace.wordpress.com/">Chemical Space</a><br>
<a href="http://baoilleach.blogspot.com/">Noel O'Blog</a><br>
<a href="http://invivoblog.blogspot.com/">In Vivo Blog</a><br>
<a href="http://cenblog.org/terra-sigillata/">Terra Sigilatta</a><br>
<a href="http://blogs.bbsrc.ac.uk/">BBSRC/Douglas Kell</a><br>
<a href="http://blog.chembark.com/">ChemBark</a><br>
<a href="http://realizationsinbiostatistics.blogspot.com/">Realizations in Biostatistics</a><br>
<a href="http://chemjobber.blogspot.com/">Chemjobber</a><br>
<a href="http://www.pharmalot.com/">Pharmalot</a><br>
<a href="http://www.chemspider.com/blog/">ChemSpider Blog</a><br>
<a href="http://pharmagossip.blogspot.com/">Pharmagossip</a><br>
<a href="http://synchemist.blogspot.com/">Med-Chemist</a><br>
<a href="http://organicchemistry-educationandindustry.blogspot.com/">Organic Chem - Education &amp; Industry</a><br>
<a href="http://www.pharmastrategyblog.com/">Pharma Strategy Blog</a><br>
<a href="http://chem.vander-lingen.nl/">No Name No Slogan</a><br>
<a href="http://practicalfragments.blogspot.com/">Practical Fragments</a><br>
<a href="http://www.simbiosys.ca/blog/">SimBioSys</a><br>
<a href="http://ashutoshchemist.blogspot.com/">The Curious Wavefunction</a><br>
<a href="http://naturalproductman.wordpress.com/">Natural Product Man</a><br>
<a href="http://fbdd-lit.blogspot.com/">Fragment Literature</a><br>
<a href="http://www.rscweb.org/blogs/cw/">Chemistry World Blog</a><br>
<a href="http://syntheticnature.wordpress.com/">Synthetic Nature</a><br>
<a href="http://www.chemistry-blog.com/">Chemistry Blog</a><br>
<a href="http://syntheticorganic.blogspot.com/">Synthesizing Ideas</a><br>
<a href="http://mndoci.com/">Business|Bytes|Genes|Molecules</a><br>
<a href="http://www.eyeonfda.com/">Eye on FDA</a><br>
<a href="http://chemicalforums.com/">Chemical Forums</a><br>
<a href="http://depth-first.com/">Depth-First</a><br>
<a href="http://blog.symyx.com/">Symyx Blog</a><br>
<a href="http://blogs.nature.com/thescepticalchymist/">Sceptical Chymist</a><br>
<a href="http://gaussling.wordpress.com/">Lamentations on Chemistry</a><br>
<a href="http://comporgchem.com/blog/">Computational Organic Chemistry</a><br>
<a href="http://miningdrugs.blogspot.com/">Mining Drugs</a><br>
<a href="http://www.ch.ic.ac.uk/rzepa/blog/">Henry Rzepa</a><br>
<br><br>
Science Blogs and News:
<br>
<a href="http://www.badscience.net/">Bad Science</a><br>
<a href="http://phenomena.nationalgeographic.com/blog/the-loom/">The Loom</a><br>
<a href="http://scienceblogs.com/principles/">Uncertain Principles</a><br>
<a href="http://www.fiercebiotech.com/">Fierce Biotech</a><br>
<a href="http://dimer.tamu.edu/simplog/?blogid=3">Blogs for Industry</a><br>
<a href="http://omicsomics.blogspot.com/">Omics! Omics!</a><br>
<a href="http://youngfemalescientist.blogspot.com/">Young Female Scientist</a><br>
<a href="http://williamtozier.com/slurry">Notional Slurry</a><br>
<a href="http://arstechnica.com/journals/science.ars">Nobel Intent</a><br>
<a href="http://www.scitechdaily.com/">SciTech Daily</a><br>
<a href="http://www.scienceblog.com/cms/index.php">Science Blog</a><br>
<a href="http://www.futurepundit.com/">FuturePundit</a><br>
<a href="http://scienceblogs.com/aetiology/">Aetiology</a><br>
<a href="http://www.gnxp.com/">Gene Expression (I)</a><br>
<a href="http://blogs.discovermagazine.com/gnxp/">Gene Expression (II)</a><br>
<a href="http://www.sciencebase.com/science-blog/">Sciencebase</a><br>
<a href="http://scienceblogs.com/pharyngula/">Pharyngula</a><br>
<a href="http://scientopia.org/blogs/ethicsandscience/">Adventures in Ethics and Science</a><br>
<a href="http://www.transterrestrial.com/">Transterrestrial Musings</a><br>
<a href="http://science.slashdot.org/">Slashdot Science</a><br>
<a href="http://blogs.discovermagazine.com/cosmicvariance/">Cosmic Variance</a><br>
<a href="http://www.biologynews.net/">Biology News Net</a><br>
<br><br>
Medical Blogs<br>
<a href="http://www.medrants.com/">DB's Medical Rants</a><br>
<a href="http://www.sciencebasedmedicine.org/">Science-Based Medicine</a><br>
<a href="http://www.gruntdoc.com/">GruntDoc</a><br>
<a href="http://scienceblogs.com/insolence/">Respectful Insolence</a><br>
<a href="http://www.diabetesmine.com/">Diabetes Mine</a><br>
<br><br>
Economics and Business<br>
<a href="http://www.marginalrevolution.com/">Marginal Revolution</a><br>
<a href="http://volokh.com/">The Volokh Conspiracy</a><br>
<a href="http://www.knowledgeproblem.com/">Knowledge Problem</a><br>
<br><br>
Politics / Current Events<br>
<a href="http://www.dynamist.com/weblog/index.html">Virginia Postrel</a><br>
<a href="http://www.pajamasmedia.com/instapundit">Instapundit</a><br>
<a href="http://pajamasmedia.com/richardfernandez/">Belmont Club</a><br>
<a href="http://kausfiles.com/">Mickey Kaus</a><br>
<br><br>
Belles Lettres<br>
<a href="http://uncouthreflections.wordpress.com/">Uncouth Reflections</a><br>
<a href="http://www.aldaily.com/">Arts and Letters Daily</a><br></div></td>
<td valign="top" width="100%">
<div class="bulletin"><div class="bulletin-background"><span class="bulletin-title">In the Pipeline:</span> Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at <strong><a href="http://pipeline.corante.com/">In the Pipeline</a></strong></div></div>

<img src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/spacecase.gif" height="1" border="0" width="350">

<h2><a href="http://pipeline.corante.com/"><img class="blogtitle" src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/title.gif" alt="In the Pipeline" border="0"></a></h2>

<div id="blog">
<div class="blogbody">

<p align="center">
<a href="http://pipeline.corante.com/archives/2013/05/02/aveo_gets_bad_news_on_tivozanib.php">« Aveo Gets Bad News on Tivozanib</a> |

<a href="http://pipeline.corante.com/">Main</a>
| <a href="http://pipeline.corante.com/archives/2013/05/06/the_medical_periodic_table.php">The Medical Periodic Table »</a>

</p>

<h4>
May  3, 2013
</h4>


<!--STANDARD ENTRY -->

<h3>Drug Assay Numbers, All Over the Place</h3><span class="printemail"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#zemail"><img class="print" src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/email.gif" alt="Email This Entry" border="0"></a></span>

<p class="author">
Posted by <span class="authorname">Derek</span>
</p>
<div class="img">
<p>There's a <a href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062325">truly disturbing paper</a> out in <i>PLoSONE</i>
 with potential implications for a lot of assay data out there in the 
literature. The authors are looking at the results of biochemical assays
 as a function of how the compounds are dispensed in them, pipet tip 
versus <a href="http://en.wikipedia.org/wiki/Acoustic_droplet_ejection">acoustic</a>,
 which is the sort of idea that some people might roll their eyes at. 
But people who've actually done a lot of biological assays may well feel
 a chill at the thought, because this is just the sort of you're-kidding
 variable that can make a big difference.</p>

<p><i></i></p><blockquote><i>Dispensing and dilution processes may 
profoundly influence estimates of biological activity of compounds. 
Published data show Ephrin type-B receptor 4 IC50 values obtained via 
tip-based serial dilution and dispensing versus acoustic dispensing with
 direct dilution differ by orders of magnitude with no correlation or 
ranking of datasets.</i></blockquote><p></p>

<p>Lovely. There have been some alarm bells sounded before about disposable-pipet-tip systems. The <a href="http://pipeline.corante.com/archives/2008/08/29/sticky_containers_vanishing_drugs.php">sticky-compound problem</a>
 is always out there, where various substances decide that they like the
 plastic walls of the apparatus a lot more than they like being in 
solution. That'll throw your numbers all over the place. And there have 
been <a href="http://dx.doi.org/10.1126/science.1162395">concerns</a> about bioactive substances <a href="http://dx.doi.org/10.1177/1087057109336594">leaching out</a>
 of the plastic. (Those are just two recent examples - this new paper 
has several other references, if you're worried about this sort of 
thing).</p>

<p>This paper seems to have been set off by two recent AstraZeneca 
patents on the aforementioned EphB4 inhibitors. In the assay data 
tables, these list assay numbers as determined via both dispensing 
techniques, and they are indeed all over the place. One of the authors 
of this new paper is from Labcyte, the makers of the acoustic dispensing
 apparatus, and it's reasonable to suppose that their interactions with 
AZ called their attention to this situation. It's also reasonable to 
note that Labcyte itself has an interest in promoting acoustic 
dispensing technology, but that doesn't make the numbers any different. 
The fourteen compounds shown are invariably less potent via the classic 
pipet method, but by widely varying factors. So, which numbers are 
right?</p>

<p>The assumption would be that the more potent values have a better 
chance of being correct, because it's a lot easier to imagine something 
messing up the assay system than something making it read out at greater
 potency. But false positives certainly exist, too, so the authors used 
the data set to generate a possible pharmacophore for the compound 
series using both sets of numbers. And it turns out that the one from 
the acoustic dispensing runs gives you a binding model that matches 
pretty well with reality, while if you use the pipet data you get 
something broadly similar, but missing some important contributions from
 hydrophobic groups. That, plus the fact that the assay data shows a 
correlation with logP in the acoustic-derived data (but not so much with
 the pipet-derived numbers) makes it look like the sticky-compound 
effect might be what's operating here. But it's hard to be sure:</p>

<p><i></i></p><blockquote><i>No previous publication has analyzed or 
compared such data (based on tip-based and acoustic dispensing) using 
computational or statistical approaches. This analysis is only possible 
in this study because there is data for both dispensing approaches for 
the compounds in the patents from AstraZeneca that includes molecule 
structures. We have taken advantage of this small but valuable dataset 
to perform the analyses described. Unfortunately it is unlikely that a 
major pharmaceutical company will release 100's or 1000's of compounds 
with molecule structures and data using different dispensing methods to 
enable a large scale comparison, simply because it would require 
exposing confidential structures. To date there are only scatter plots 
on posters and in papers as we have referenced, and critically, none of 
these groups have reported the effect of molecular properties on these 
differences between dispensing methods.</i></blockquote><br>
<img alt="Acoustic.png" src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/Acoustic.png" height="445" width="694"><br>
Some of those other references are to posters and meeting presentations,
 so this seems to be one of those things that floats around in the field
 without landing explicitly in the literature. One of the paper's 
authors was good enough to send along the figure shown, which brings 
some of these data together, and it's an ugly sight. This paper is 
probably doing a real service in getting this potential problem out into
 the cite-able world: now there's something to point at.<p></p>

<p>How many other datasets are hosed up because of this effect? Now 
there's an important question, and one that we're not going to have an 
answer for any time soon. For some sets of compounds, there may be no 
problems at all, while others (as that graphic shows) can be a mess. 
There are, of course, plenty of projects where the assay numbers seem 
(more or less) to make sense, but there are plenty of others where they 
don't. Let the screener beware.</p>

<p><i>Update: here's <a href="http://www.collabchem.com/2013/05/03/what-it-took-to-get-the-paper-out/">a behind-the-scenes look</a> at how this paper got published. It was not an easy path into the literature, by any means.</i></p>

<p><i>Second update: <a href="http://blogs.nature.com/methagora/2013/05/serial-dilution-woes.html">here's more</a> about this at Nature Methods.</i></p>
<a name="more"></a>
</div>


<p class="posted">
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#comments">Comments (47) </a>
+ <a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#comments">TrackBacks (0)</a> | Category: <a href="http://pipeline.corante.com/archives/drug_assays/">Drug Assays</a> 
</p>



<!-- BLINK -->



<!-- SPONSORED POST -->


 


<br>

<!-- COMMENTS DISPLAY -->




<div class="comments">
<a name="comments"></a><b>COMMENTS</b>
<div id="commentflop">
<p class="commentsbody"><a name="1208425"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208425">1. </a></span><span style="color:#036">BHip </span> on May  3, 2013  8:18 AM writes...</p>
<p>Speaking as someone on the assay side, I know this is the kind of thing that drives medicinal chemist’s berserk. <br>
Something obvious to keep in mind- the tips are not the only potential 
source of spurious compound binding in the assays (potency shifts due to
 the plates, beads, etc.??). </p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208425">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208426"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208426">2. </a></span><span style="color:#036">SP </span> on May  3, 2013  8:20 AM writes...</p>
<p>You're more likely to have false positives in cell-based assays, 
where a pin tool or pipettor dumps a blob of concentrated compound in 
high percentage DMSO that sinks onto the cell monolayer at the bottom of
 the well before dispersing.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208426">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208443"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208443">3. </a></span><span style="color:#036">JeffC </span> on May  3, 2013  9:36 AM writes...</p>
<p>Aint no substitute for repeats. Different days, different biologists.
 Tends to pick up experimental error. And retesting from solid. </p>

<p>This emphasises the massive risks in the virtual, outsourced drug 
discovery model. It might be lean and capital efficient but if your 
scientists aren't talking to each other every day face-to-face these 
types of issues are going to bite you in the ass. Probably once you've 
spent all that lean cash.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208443">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208448"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208448">4. </a></span><span style="color:#036">ADCchem </span> on May  3, 2013  9:39 AM writes...</p>
<p>Interesting study. My experience with nanomolar to picomolar greasy 
compounds is quite the opposite. That is picomolar dilutions tend to be 
more concentrated as the greasy compounds stick to the plastic tips and 
are transferred to the cellular assay at higher then diluted 
concentrations. In general greasy compounds IC50s tend to be lower then 
expected at these concentrations. It would be interesting to see how the
 acoustic based method performs on low concentration assays. </p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208448">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208452"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208452">5. </a></span><span style="color:#036">Anonymous </span> on May  3, 2013  9:51 AM writes...</p>
<p>"3. JeffC on May 3, 2013 9:36 AM writes...</p>

<p>Aint no substitute for repeats. Different days, different biologists.
 Tends to pick up experimental error. And retesting from solid." </p>

<p>This is potentially where you can get caught out. The IC50s by both 
tip and acoustic dispencers are reproducible, just reproduciably 
different. So your n=3 might make you happy that you've got the right 
result, but you haven't. That's why your blood should run cold.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208452">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208459"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208459">6. </a></span><span style="color:#036">JeffC </span> on May  3, 2013 10:26 AM writes...</p>
<p>5.</p>

<p>I agree to some extent with what you say but typically a biologists 
will use one pipette that is "theirs" but maybe completely different 
from another person in the same lab doing the same assay. This is a 
physical effect essentially and while it's beautifully repeatable across
 a single device if you have biologists using multiple devices I suspect
 that's when you'll see variation and the alarm bells will start 
ringing. Additionally, some biologists will dilute their samples one 
way, and another will do it slightly differently. The theoretical 
concentration is the same but how they get there is different. All of 
these things will increase the chance of you seeing odd results or 
things that don't quite make sense. But only if you are actually talking
 to the people doing the work. All the time.</p>

<p>I'm not disagreeing with you. This yet another way in which things 
can get messed up. But my point is that a good team that is talking 
about the results being generated all the time will stand a far better 
chance of picking this type of thing up before they find the compound 
tanks in the Phase 2 POC trial.</p>

<p></p>

<p>I</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208459">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208462"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208462">7. </a></span><span style="color:#036">RD </span> on May  3, 2013 10:40 AM writes...</p>
<p>Well, this explains a lot of pointless team meetings and SAR that went nowhere.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208462">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208467"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208467">8. </a></span><span style="color:#036">Computationally Entertained </span> on May  3, 2013 10:58 AM writes...</p>
<p>It reminds me of the complaints I had for a recent paper titled "do medicinal chemists learn from activity cliffs? ..."</p>

<p><a href="http://pubs.acs.org/doi/abs/10.1021/jm400147j" rel="nofollow">http://pubs.acs.org/doi/abs/10.1021/jm400147j</a></p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208467">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208470"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208470">9. </a></span><span style="color:#036">Stephan </span> on May  3, 2013 11:06 AM writes...</p>
<p>I think (hope) everybody in assay development is familiar with the sticky wall and volatile plate issues.<br>
Our production folks certainly are. If I ask them to package 100Âµl of 
1Âµg/ml (there aren't any moles in their lab) detector antibody they ask
 if that is for immediate use (fine) use any time after after 2 weeks @ 
4Â°C (fine, they will adjust the conc.), or to be used anywhere between 
12h and 14 days after bottling (good luck, you are on your own).</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208470">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208472"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208472">10. </a></span><span style="color:#036">Anonymous </span> on May  3, 2013 11:12 AM writes...</p>
<p>6.</p>

<p>I completely agree with the second bit. And a good dialogue with the 
screener in the team can really help when the correlations get messy for
 other reasons too.</p>

<p>If you really are screening with a biologist and their favourite 
pipette then you might want to think about changing that. Using 
standardised automated processes can really help to minimise those kinds
 of differences.<br>
</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208472">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208474"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208474">11. </a></span><span style="color:#036">Cellbio </span> on May  3, 2013 11:12 AM writes...</p>
<p>Agree with ADCchem.  Jeff, it is more about sticking to plastic and 
method than specific device or operator.  Worked with a compound that 
showed 3 orders of magnitude difference in apparent IC50 depending upon 
whether one changed tips between dilution, with no tip change appearing 
more potent.  For a really greasy compound, now a marketed drug, 
dilution in media without serum approached micromollar, low nanomolar 
with serum, sub-picomolar formulated in micelles.  Came to conclude that
 just as mg/kg dosing is not a valid way to infer in vivo exposure, 
inferring intrinsic target potency from concentrations expected from 
dilution schemes is flawed, as many factors such as plastic binding, 
protein binding etc are integrated.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208474">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208495"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208495">12. </a></span><span style="color:#036">darwinsdog </span> on May  3, 2013 12:04 PM writes...</p>
<p>In additional to adhesion to plastic surfaces, I would wonder about 
aggregation of cmpds (think Brian Shoichet) or other physical effects 
related to the properties of each cmpd that manifest by diff. 
dispensation methods.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208495">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208501"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208501">13. </a></span><span style="color:#036">JC </span> on May  3, 2013 12:16 PM writes...</p>
<p>Never look at the IC50 curves; you will go mad.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208501">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208502"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208502">14. </a></span><span style="color:#036">Hap </span> on May  3, 2013 12:21 PM writes...</p>
<p>12 - I thought the detergent-added runs were supposed to prevent that
 - are detergents generally unable to break aggregates already formed?</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208502">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208503"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208503">15. </a></span><span style="color:#036">Cialisize Me </span> on May  3, 2013 12:22 PM writes...</p>
<p>Isn't the best way to perform biochemical IC50s is to do your serial 
dilutions *first* into straight DMSO followed by addition of a small amt
 of these to your reaction well. That way you know that the actual amt 
of compound got into the well.  This works for any method, pipette or 
acoustic. It solves your sticky pipette problem or crashing out at 
higher concs. Your enzyme has to be able to  function in a percent or 
two DMSO, but most times this is OK. C-M</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208503">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208504"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208504">16. </a></span><span style="color:#036">Hap </span> on May  3, 2013 12:24 PM writes...</p>
<p>12 - I thought the detergent-added runs were supposed to prevent that
 - are detergents generally unable to break aggregates already formed?</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208504">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208510"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208510">17. </a></span><span style="color:#036">Algirdas </span> on May  3, 2013 12:44 PM writes...</p>
<p>@14 Hap,</p>

<p>I wonder exactly how does adding detergent work? I have not done this
 myself, but I do have an assay featuring a greasy compound, which may 
benefit from added detergent. But... one might imagine two scenarios:</p>

<p>i) no detergent. Greasy compound aggregates, effective dissolved conc is tiny, assay shows no effect.</p>

<p>ii) with detergent, greasy compound partitions into mixed micelles, effective dissolved conc is tiny, assay shows no effect.</p>

<p>Are improvements seen with the addition of the detergent large? Like, orders of magnitude-large?<br>
</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208510">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208515"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208515">18. </a></span><span style="color:#036">Anonymous </span> on May  3, 2013  1:01 PM writes...</p>
<p>@ 17 they can be very large differences. And it depends on how your 
compounds are acting. It can either help stabilise compounds in solution
 and so you get an increase in potency or (this us the one I've seen 
more often) your cpds in the absence of detergent are forming aggregates
 and giving non-specific inhibition, in which case adding detergent gets
 rid of this activity.</p>

<p>Brian Shiochet's papers have a lot on assays with/without detergent.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208515">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208517"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208517">19. </a></span><span style="color:#036">Hap </span> on May  3, 2013  1:08 PM writes...</p>
<p>17: I haven't done used detergen in drug assays (because I don't work
 in lab), but there has been a lot of discussion about it here. If using
 detergent doesn't help with aggregation in the pipet (doesn't break up 
already-formed aggregates), you might still have problems with your 
assays when you think you don't. </p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208517">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208519"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208519">20. </a></span><span style="color:#036">smurf </span> on May  3, 2013  1:21 PM writes...</p>
<p>at 17, 18: orders of magnitude differences are possible.</p>

<p>Use Pluronics in your assay and solubilisation buffer, e.g. F-127. It
 is biocompatible, and actually not a detergent. Helps a lot.</p>

<p>Be careful how you dissolve the solid, the exact path from solid 
compound to assay data does matter. It's anal stuff, unfortunately still
 more art than science: most people don't care.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208519">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208522"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208522">21. </a></span><span style="color:#036">darwinsdog </span> on May  3, 2013  1:35 PM writes...</p>
<p>@16,19  First of all the paper in question is a meta analysis of data
 from other papers. So take it for what it is worth and realize that a 
lot more may be a variable here than just the dispensation method alone 
(usual list when changing assay protocols all the way to material lots 
over time) but it makes for a point to blog about and count as a PLOS 
publication (for whatever that gets you). But back to the detergent 
control - I do not know if the original papers included detergent 
controls in an attempt to address aggregation but I can tell you in 
general pharma companies (at least the ones I know about first hand) 
don't usually dedicate wells in a plate to this type of control (I guess
 the cmpd libraries  are deemed to sufficiently cover the 
'palmolive-space' :-).  </p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208522">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208525"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208525">22. </a></span><span style="color:#036">Anonymous </span> on May  3, 2013  1:41 PM writes...</p>
<p>I tend to use tween / triton  and am with 15 in dissolving in DMSO 
then adding a small volume to the assay. I think that's what they do in 
the paper Derek blogged about too?</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208525">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208526"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208526">23. </a></span><span style="color:#036">smurf </span> on May  3, 2013  1:46 PM writes...</p>
<p>at 15: yes, that's the best way. From solid into DMSO, then 
sonication, then serialisation, then dilution in solubilisation buffer, 
then assay buffer. Acoustic dispensing works very well, still, for key 
compounds I used to repeat the data as described, often from different 
batches or from solid compound sources.</p>

<p>And stats matters, number of data points matter, multiple repeat 
experiments at different days matter: managers don't like it, but it 
DOES matter. Ideally the assay and screening biologists should be in 
daily contact with the chemists to ensure that key compounds are 
repeated again and again to establish a solid data set.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208526">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208539"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208539">24. </a></span><span style="color:#036">cdsouthan </span> on May  3, 2013  2:53 PM writes...</p>
<p>Time for a CASFEAR competition  "Critcal Assesment For Enzyme Assay Reproducability"</p>

<p>Just send a few reference compounds (with LogP spread) out to 20 to 
50 labs and ask for the IC50s and Ki's back with some linearity curves 
thrown in.  Then write the paper. </p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208539">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208551"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208551">25. </a></span><span style="color:#036">Hap </span> on May  3, 2013  3:28 PM writes...</p>
<p>I can see why it wasn't in Science, but I wouldn't have agreed that it belonged in a medicinal chemistry journal. </p>

<p>How do journals get all the pretty biological data they show? In some
 cases (maybe a lot), there aren't exogenous components in the assays or
 their standards and so aggregation/other issues during dispensing 
aren't issues, but in the remaining cases components which may not 
behave correctly are added exogenously. Without further data, you can't 
assume that all compounds behave like this (maybe the set of compounds 
used was funny in some way that led to the observed behavior), but I'd 
not be betting the house, its furniture, or even the toys that this 
doesn't happen elsewhere. Doesn't that possibility make an awful lot of 
biological data look less secure? If it does, that would be important to
 a lot of people.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208551">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208553"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208553">26. </a></span><span style="color:#036">MedChemGradStudent </span> on May  3, 2013  3:35 PM writes...</p>
<p>@17:  Check out the below linked recent article by Davis and Erlanson
 on fragment screening. It is mainly focused on fragment based screening
 concerns, but it has a section on use of detergents and other important
 general points to keep in mind when it comes to screening (not just for
 fragment based screening)</p>

<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23562240" rel="nofollow"></a><a href="http://www.ncbi.nlm.nih.gov/pubmed/23562240" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/23562240</a></p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208553">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208557"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208557">27. </a></span><span style="color:#036">Alex </span> on May  3, 2013  3:49 PM writes...</p>
<p>Seems like the authors had some fun getting the paper published, too...</p>

<p><a href="http://www.collabchem.com/2013/05/03/what-it-took-to-get-the-paper-out/" rel="nofollow"></a><a href="http://www.collabchem.com/2013/05/03/what-it-took-to-get-the-paper-out/" rel="nofollow">http://www.collabchem.com/2013/05/03/what-it-took-to-get-the-paper-out/</a></p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208557">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208558"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208558">28. </a></span><span style="color:#036">darwinsdog </span> on May  3, 2013  4:02 PM writes...</p>
<p>@25  Well Hap welcome to the world of in vitro screening.  To answer 
your first question - "graphing software". To answer your second 
question - "yes, yes it does" but everybody in the field knows this 
intimately.  Medicinal chemists, well all drug devpt scientists for that
 matter, view the screen as the means to the end or the back-story about
 how the pharmacophore came to be with the pharmacophore being the thing
 of interest.  So other than in-house use, HTS data is mainly used as 
claims in patent filings and has all the robustness and validation 
implied by that.  Said another way, if you have a critical decision to 
make on your own research don't base it on screening data that someone 
else has published.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208558">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1208579"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208579">29. </a></span><span style="color:#036">anon </span> on May  3, 2013  5:24 PM writes...</p>
<p>well, you shouldn't get too excited anyway until you get confirmatory
 activity in a totally different, low-throughput, manually pipetted 
assay</p>

<p>but still it affects what "best" compounds ever go into those</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208579">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1208634"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208634">30. </a></span><span style="color:#036">Jose </span> on May  3, 2013 10:40 PM writes...</p>
<p>I think it's an important finding, but did they seriously think it was Science worthy enough to submit not once, but TWICE?</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1208634">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1209019"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1209019">31. </a></span><span style="color:#036"><a href="http://larsduelund.wordpress.com/" rel="nofollow">Lars Duelund</a> </span> on May  5, 2013  6:39 AM writes...</p>
<p>Two things here:<br>
First I think PLoS One is a good place for studies like this. Everybody 
can get access to this work, also the people working in small 
organisation.</p>

<p>Second, and I know it is a bit ot I know, but the pipettes with 
disposable tips are probably the most misused piece of lab equipment 
around. Just recently I have encountered a post doc, complaining to me 
that when he pipetted 1.5 mL chloroform into a 2 ml vial there was more 
than 2 ml of solvent... First off, CHCl3 in single use plastic tip will 
not give the right volume, never. The second mistake was that the knob 
was pushed all the way down, as for emptying the tip, both when filling 
and emptying it, hence the more than 2 ml solvent. And I was also told 
about the professor with several PNAS papers who also had done the same 
all hes carrier. </p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1209019">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1209238"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1209238">32. </a></span><span style="color:#036">Anne </span> on May  6, 2013 12:58 AM writes...</p>
<p>@Lars: I vividly remember the moment, during my very first lab 
research experience (the summer after freshman year of college), when I 
realized that I had been pipetting incorrectly all summer, pushing the 
knob down fully to pull up small quantities of a very expensive drug. 
This explained why I had run out of the drug so quickly (though as this 
was 2006 my boss had no problem dropping a few thousand on another 
batch). I then had to recalculate the actual drug dosages I had used in 
my experiments, and my data ended up being labeled as "high" and 
"normal" concentrations... I was profoundly embarrassed and terrified to
 tell my boss. Luckily he was kind and understanding I'm just glad I 
realized this at such an early and low stakes stage of my research 
career. I can't imagine making it to postdoc, much less professor, 
without knowing how to pipet properly...</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1209238">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1209548"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1209548">33. </a></span><span style="color:#036">Sean Ekins </span> on May  6, 2013 10:42 AM writes...</p>
<p>Thank you Derek for highlighting the paper and the blog. Also a thank
 you to the conmmentors. I would like to respond to them all but I just 
do not have the time or the knowledge on some of the issues raised 
to..so I hope this suffices. I have added a bit more analysis behind why
 this work gives me nightmares on my blog and 
(http://www.collabchem.com/2013/05/06/why-does-this-issue-still-give-me-nightmares/)
 and answered just a few of the comments relating to the visibility of 
the "stickiness/ leaching" issue and also why we tried "Science" so 
rather than repeat myself...Would be happy if people can find any other 
datasets that we could analyze using multiple dispensing methods, also 
anyone at AZ want to send us the compounds in the paper and we can 
probably find collaborators that would test many of the hypotheses set 
forth in the comments above? I sense this is just the begininng of 
trying to get to the cause of what we and others have seen. I regret we 
are the ones that are getting attention when really those in the figure 
Derek used should be the ones we look to and thank for bringing the 
issue to the public attention.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1209548">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1210225"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1210225">34. </a></span><span style="color:#036">sgcox </span> on May  7, 2013  4:39 AM writes...</p>
<p>~20 smurf: <br>
never tried Pluronics before.<br>
What concentration would you recommend?<br>
Should it be used in addition to detergent or instead ? thank you.</p>

<p> </p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1210225">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1210526"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1210526">35. </a></span><span style="color:#036">Joe </span> on May  7, 2013  1:02 PM writes...</p>
<p>A blog from Nature Methods comments on the original PLOSONE paper at <a href="http://blogs.nature.com/methagora/2013/05/serial-dilution-woes.html" rel="nofollow">http://blogs.nature.com/methagora/2013/05/serial-dilution-woes.html</a> </p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1210526">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1211036"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1211036">36. </a></span><span style="color:#036">DaveK </span> on May  8, 2013  7:47 AM writes...</p>
<p>Acoustic dispensing makes a difference?  Oh no, maybe the homeopaths were onto something with their succussion all along!  ;-)<br>
</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1211036">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1211616"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1211616">37. </a></span><span style="color:#036">cdsouthan </span> on May  9, 2013  4:34 AM writes...</p>
<p>Comparative characteristion of the basic dilution linearity could be 
useful, before layering on the complications of compounds and proteins. 
Manual Gilson vs tip  vs acoustic robots could be run with a robust 
chromophoric reagent and even corroborated by uHPLC to check in = out </p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1211616">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1211878"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1211878">38. </a></span><span style="color:#036">KA1OS </span> on May  9, 2013  2:33 PM writes...</p>
<p>The somewhat scary thing about dilutions in various solutions is that
 they can be extremely reproducible. Low variation tells you nothing 
about whether the results are accurate. What we end up doing is 
increasing the number of mix cycles until the variation goes away. 
Without an independent control or way of measuring, you can't know.</p>

<p>#15 Cialize Me, #23 smurf -- I agree. If your compounds start in 
DMSO, keep all manipulations in that solvent as far into the process as 
possible. Note that acoustic dispensing often still requires three to 
four intermediate pre-dilution steps to compensate for the limit 
dispense range of these instruments (Acoustic dispensers typically 
provide 2.5 nL - 250 nL dispense volumes, only a 100-fold working 
range). The HP 'inkjet' dispenser provides a wider range but still 
cannot cover that needed for a 10-point, half-log curve.</p>

<p>I am familiar with the AZ studies which compare Echo dispensing 
against aqueous dilution (the latter case being significantly bad), but 
if anyone has a comparison against tip-based serial dilutions in DMSO, 
I'd appreciate any reference. I can say that we have seen differences 
between acoustic dispensing and serial-dilutions in DMSO *if* there is 
an aqueous buffer step just prior to final plating. </p>

<p>I've also wondered for years how much pre-dispensed (or dry-dotted) 
plates created before adding assay reagents may exhibit problems. This 
would be tested against assay runs where the compounds are added after 
many of the reagents.</p>

<p>I suppose the ultimate would be running assays in 
electrostically-suspended droplets with no external surfaces to bind 
compounds.</p>

<p>- Tim</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1211878">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1212462"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1212462">39. </a></span><span style="color:#036">RB Davis </span> on May 10, 2013  2:48 PM writes...</p>
<p>Decades ago in my analytical chem days (HPLC) I worked with hazardous
 and toxic industrial and agrichemicals.  Some of them very much 
preferred sticking to a plastic pipetter tip over going into the 
alcohol, acetonitrile, or MECl2 they were supposed to be dissolved in.</p>

<p>The GC guys down the hall had long-since standardized on positive 
displacement micropipetters with a clear glass tube and PTFE piston.  
They were a little fiddlier to work with than the plastic wonders 
favored by the bio lab people, but they delivered outstanding accuracy 
and it was easy to visually verify that the gunk of interest was indeed 
no longer stuck to the piston or tube before pitching the tube and 
washing the piston with a squirt bottle.  </p>

<p>The air void plastic pipetters were always wildly inaccurate by our 
standards and the chemical affinity and contamination issues of the tips
 made them untrustworthy for our assays (purity, and concentration work,
 mostly) anyway.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1212462">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1213869"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1213869">40. </a></span><span style="color:#036"><a href="http://www.collaborativedrug.com/" rel="nofollow">Sylvia</a> </span> on May 13, 2013  2:55 PM writes...</p>
<p>While this is "truly disturbing" and probably means that a lot of 
time and money has been wasted - and it also explains all the 
disappointing news on drugs which were thought to be great candidates 
(until they failed efficacy in clinical trials)...to me this also sounds
 like the dawn of a new era, sort of a potentially looming gold-rush. </p>

<p>All those compounds which could have been the desired next 
block-buster and which have escaped discovery so far due to simply how 
they were dispensed - they are still out there. Waiting to be 
identified, to become new drugs.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1213869">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1214403"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1214403">41. </a></span><span style="color:#036"><a href="http://www.linkedin.com/in/drandrewray" rel="nofollow">Andrew Ray</a> </span> on May 14, 2013 12:54 PM writes...</p>
<p>Sylvia - Be careful not to make too many assumptions in the other 
direction...that is, don't assume that sticky walls and other 
pipette-related "errors" explain all efficacy failures.  For example, 
those recent Alzheimer's antibody failures are probably more likely the 
result of theoretical problems due to our still-limited understanding of
 AD.  Sometimes, too, you'll run into 100% water soluble, nonsticky 
compounds where differences in animal model/human metabolism causes them
 the impress during preclinical tests, then fail during clinical tests.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1214403">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1218060"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1218060">42. </a></span><span style="color:#036">Joe </span> on May 20, 2013  1:31 PM writes...</p>
<p>@20, @34. Note that Pluronics, contrary to earlier beliefs, do have 
biological affects on their own and with other drugs. See some of the 
papers by Alexander Kabanov on the impact of Pluronics on cells</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1218060">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1219876"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1219876">43. </a></span><span style="color:#036">Joe </span> on May 23, 2013  1:03 PM writes...</p>
<p>@4 I agree that people often believe that hydrophobic compounds are 
transferred at higher concentrations than expected in serial dilutions. 
Michael 
Berger(https://www.researchgate.net/post/Have_you_had_experiences_of_dispensing_processes_affecting_your_high-throughput_screening_results#rg-injektor-generated-rg_modules_publictopics_actions_PostCommentItemProxy519e58e6d11b8bf57e000002-)
 definitely agrees with you. However, the data in the patents from 
AstraZeneca suggest that tips are doing the exact opposite of this--they
 are reducing the concentration of the test compound as the dilutions 
are attenuated. This is also seen in Harris D, Olechno J, Datwani S, 
Ellson R, Gradient, contact-free volume transfers minimize compound loss
 in dose-response experiments. J Biomol Screen 2010 15: 86â€“94. Data 
from Bristol-Myers Squibb (Spicer T, Fitzgerald Y, Burford N, Matson S, 
Chatterjee M, Gilchrist M, Myslik J and Oâ€™Connell J. 2005 
Pharmacological evaluation of different compound dilution and transfer 
paradigms on an enzyme assay in low volume 384-well format. Drug 
Discovery Technology. Boston) suggests that the compound that exhibited 
the greatest loss of material during transfer had a logP value of 2.87.<br>
I think that dilutions, an area that one might expect to be simple, are 
actually fraught with complications and deserve more attention. I hope 
that researchers will read the PLOS ONE article and that pharmaceutical 
companies (the holders of much similar data) will release the data for 
subsequent analyses. </p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1219876">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1225310"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1225310">44. </a></span><span style="color:#036">Anne Carpenter </span> on June  3, 2013  8:26 AM writes...</p>
<p>In response to the request for other studies of dispensing methods, 
this one compares acoustically-prepared pre-plated compounds vs pin 
tool:<br>
<a href="http://jbx.sagepub.com/content/18/1/14.abstract" rel="nofollow">http://jbx.sagepub.com/content/18/1/14.abstract</a><br>
</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1225310">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1248272"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1248272">45. </a></span><span style="color:#036">ben schenker </span> on July 13, 2013  9:36 AM writes...</p>
<p>I didn't see anything in the PLoS one publication that references 
that the compounds may be 'sticking' to the tips. It does mention 
leachates, but then cites 4 pubs which say leachates come from all 
plasticware (including plates which acoustic devices use for storage and
 dispensing) and that leachates inhibit biological pathways, leading to 
greater perceived potency. This would seem to contradict what the 
authors are suggesting. The major difference would seem to be the use of
 high volume versus low volume liquid handling for setting up the 
dilution and assay plates, with the former potentially causing compounds
 to partially crash out of solution - this is not really a new idea 
though.</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1248272">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="1304841"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1304841">46. </a></span><span style="color:#036">Sarah </span> on November  7, 2013  9:38 AM writes...</p>
<p>Just to point out the 'nice' table showing the 4 comparative studies 
between acoustic and tip-based dispensing (Table 3) in the PLoS ONE 
paper contains only 1 study that is peer reviewed! In addition the 
'published data' that are the basis of the whole paper is data from 
patent applications NOT peer reviewed publications - call me old 
fashioned but if it isn't peer reviewed then I don't take much notice of
 it....not that all peer reviewed papers are perfect either!</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1304841">Permalink to Comment</a> 
<p></p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="1468542"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1468542">47. </a></span><span style="color:#036">Olechno </span> on May 20, 2014  7:34 PM writes...</p>
<p>In response to Sarah (@46), I am one of the authors of the PLOS ONE 
paper. I agree that patent data is not always the best source. I have 
seen patents suggesting that dowsing rods work. But one works with the 
data one has. As we pointed out in our peer-reviewed paper, we would be 
very excited to see someone do a comparison of a larger number of 
compounds. I suppose that it is possible that both AZ and BMS 
independently generated errors that trend in the same ways despite using
 different targets, different libraries and different assays. This, 
however, seems to be inventing reasons why not to believe the work is 
meaningful. It seems odd to discount the non-peer-reviewed patent data 
when we show that the direct dilution pharmacophore from that data was 
very similar to the pharmacophore from X-ray crystallography while the 
pharmacophore from serial dilution was both very different and 
non-predictive.  I know that I can speak for my co-authors and state 
that we would be delighted to work with you or any others to run 
comprehensive tests and to nail down the effect (or non-effect) that we 
reported. I have asked groups to extend the work presented at the podium
 or at posters. I have been told that the research groups have made 
their decisions and see no reason to publish. They seem to see the 
results as an advantage that they might lose upon publication. <br>
Concerning peer review, you may be interested in reading the article by John Smith, former editor of BMJ:  <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1420798/" rel="nofollow">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1420798/.</a><br>
Also, consider that excellent science has appeared in non-peer-reviewed 
books (De Revolutionibus, Principia, Origin of Species). And the 
original Einstein paper on relativity did not undergo formal peer-review
 but were printed because the editor liked them. And arXiv.org is 
particularly open to non-peer-reviewed work.<br>
</p>
<a href="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php#1468542">Permalink to Comment</a> 
<p></p>
</div>

</div>



<!-- TRACKBACKS DISPLAY -->





<!-- POST A COMMENT -->


<b>POST A COMMENT</b>

 



<form method="post" action="http://www.corante.com/cgi-bin/mt/terioria.fcgi" name="comments_form" onsubmit="if (this.bakecookie[0].checked) rememberMe(this)">
<input name="static" value="1" type="hidden">
<input name="entry_id" value="76387" type="hidden">

<div id="name_email">
<p><label for="author">Name:</label><br>
<input tabindex="1" id="author" name="author"></p>

<p><label for="email">Email Address:</label><br>
<input tabindex="2" id="email" name="email"></p>
</div>



<p><label for="url">URL:</label><br>
<input tabindex="3" name="url" id="url" type="text">
Remember Me?
<input id="remember" onclick="rememberMe(this.form)" name="bakecookie" type="radio"><label for="remember">Yes</label><input id="forget" name="bakecookie" onclick="forgetMe(this.form)" value="Forget Info" style="margin-left: 15px;" type="radio"><label for="forget">No</label><br style="clear: both;">
</p>

<div class="quicktags"><p><label for="text">Comments:</label> </p>

<script src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/quicktags.html" type="text/javascript"></script><script type="text/javascript">edToolbar();</script>

<p><br style="clear: both;">
<textarea tabindex="4" id="text" name="text" rows="10" cols="50"></textarea><script type="text/javascript">var edCanvas = document.getElementById('text');</script></p></div>


<div align="center">
<input name="preview" tabindex="5" value=" Preview " type="submit">
<input style="font-weight: bold;" name="post" tabindex="6" value=" Post " type="submit">
</div>
</form>




<script language="javascript" type="text/javascript" src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/comment_form.html"></script>






<!-- EMAIL THIS ENTRY -->

<a name="send"></a>
<form method="post" action="http://www.corante.com/cgi-bin/mt/mt-send-entry.cgi">
<input name="entry_id" value="76387" type="hidden">
<input name="_redirect" value="http://pipeline.corante.com/archives/2013/05/03/drug_assay_numbers_all_over_the_place.php" type="hidden">
<br>

<p><b>EMAIL THIS ENTRY TO A FRIEND</b></p>
<a name="zemail"></a>
Email this entry to:<br>
<input name="to" size="25"><br>
Your email address:<br>
<input name="from" size="25"><br>
Message (optional):<br>
<textarea name="message" rows="5" cols="30" wrap="virtual"></textarea>
<br>
<input value="Send" type="submit">
</form>
<br>
<br>
<br>


<!-- RELATED ENTRIES -->

<dl>
<dt><b>RELATED ENTRIES</b></dt>

 
<dd>› <a href="http://pipeline.corante.com/archives/2015/01/30/sanofis_search.php">Sanofi's Search</a></dd>
 
<dd>› <a href="http://pipeline.corante.com/archives/2015/01/30/underpowered_and_overinterpreted.php">Underpowered And Overinterpreted</a></dd>
 
<dd>› <a href="http://pipeline.corante.com/archives/2015/01/30/instant_azides_and_more.php">Instant Azides, and More</a></dd>
 
<dd>› <a href="http://pipeline.corante.com/archives/2015/01/29/flex_pharmaceuticals_is_testing_what.php">Flex Pharmaceuticals Is Testing What?</a></dd>
 
<dd>› <a href="http://pipeline.corante.com/archives/2015/01/29/expensive_placebos_work_better.php">Expensive Placebos Work Better</a></dd>
 
<dd>› <a href="http://pipeline.corante.com/archives/2015/01/28/the_acs_becomes_invisible_but_not_for_long.php">The ACS Becomes Invisible (But Not For Long)</a></dd>
 
<dd>› <a href="http://pipeline.corante.com/archives/2015/01/28/cuckoo_for_publishing_fees.php">Cuckoo For Publishing Fees</a></dd>
 
<dd>› <a href="http://pipeline.corante.com/archives/2015/01/28/refold_those_proteins.php">Refold Those Proteins</a></dd>
 

</dl>


</div>
</div>
</td>


<td id="rlinks" valign="top">
<table border="0" cellpadding="0" cellspacing="0" width="190">
<tbody><tr>
<td>

<div class="tablead" style="background:#fff;font-size:100%;text-align:left">

<br><br>
<div id="recent_entries">
<div class="sidetitle">RECENT ENTRIES</div>
<div class="rside">
<b>›</b> <a href="http://pipeline.corante.com/archives/2015/05/26/the_curse_of_expertise.php">The Curse of Expertise</a><br><br>
<b>›</b> <a href="http://pipeline.corante.com/archives/2015/05/26/targeting_proteins_for_destruction.php">Targeting Proteins for Destruction</a><br><br>
<b>›</b> <a href="http://pipeline.corante.com/archives/2015/05/22/a_new_amination_reaction.php">A New Amination Reaction</a><br><br>
<b>›</b> <a href="http://pipeline.corante.com/archives/2015/05/21/guess_what_your_peers_are_already_reviewing_you.php">Guess What: Your Peers Are Already Reviewing You</a><br><br>
<b>›</b> <a href="http://pipeline.corante.com/archives/2015/05/21/crappy_antibodies_available_now_and_for_the_foreseeable_future.php">Crappy Antibodies: Available Now, and for the Foreseeable Future</a><br><br>
<b>›</b> <a href="http://pipeline.corante.com/archives/2015/05/20/controlling_proteins_one_by_one.php">Controlling Proteins, One by One</a><br><br>
<b>›</b> <a href="http://pipeline.corante.com/archives/2015/05/20/a_young_blood_controversy.php">A Young Blood Controversy</a><br><br>
<b>›</b> <a href="http://pipeline.corante.com/archives/2015/05/19/pfizer_rumors_again.php">Pfizer Rumors, Again</a><br><br>
<b>›</b> <a href="http://pipeline.corante.com/archives/2015/05/19/another_conservation_law.php">Another Conservation Law</a><br><br>
<b>›</b> <a href="http://pipeline.corante.com/archives/2015/05/18/nitric_acid_and_your_lab_coat.php">Nitric Acid And Your Lab Coat</a><br><br>

</div> 
</div>

<div class="sidetitle">RECENT COMMENTS <a href="http://pipeline.corante.com/25comments.xml"><span class="catxml">[xml]</span></a></div>
<div class="rside">
› Zach on <br><a href="http://pipeline.corante.com/archives/2015/05/14/the_least_useful_element_for_organic_chemistry.php#1699585">The Least Useful Element For Organic Chemistry?</a><br><br>
› Pete on <br><a href="http://pipeline.corante.com/archives/2015/05/26/the_curse_of_expertise.php#1699582">The Curse of Expertise</a><br><br>
›  on <br><a href="http://pipeline.corante.com/archives/2015/05/26/the_curse_of_expertise.php#1699581">The Curse of Expertise</a><br><br>
› RM on <br><a href="http://pipeline.corante.com/archives/2015/05/26/the_curse_of_expertise.php#1699570">The Curse of Expertise</a><br><br>
› Biotech Capitalist on <br><a href="http://pipeline.corante.com/archives/2015/05/26/the_curse_of_expertise.php#1699565">The Curse of Expertise</a><br><br>
› RM on <br><a href="http://pipeline.corante.com/archives/2015/05/26/the_curse_of_expertise.php#1699564">The Curse of Expertise</a><br><br>

</div>

<div id="archives">
<div class="sidetitle">› <a href="http://pipeline.corante.com/archives/cat_index.php">CATEGORIES</a></div>
<div id="category">
<div class="rside">
› <a href="http://pipeline.corante.com/archives/me_too_drugs/">"Me Too" Drugs (28)</a> <a href="http://pipeline.corante.com/archives/me_too_drugs.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/academia_vs_industry/">Academia (vs. Industry) (131)</a> <a href="http://pipeline.corante.com/archives/academia_vs_industry.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/aging_and_lifespan/">Aging and Lifespan (66)</a> <a href="http://pipeline.corante.com/archives/aging_and_lifespan.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/alzheimers_disease/">Alzheimer's Disease (93)</a> <a href="http://pipeline.corante.com/archives/alzheimers_disease.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/analytical_chemistry/">Analytical Chemistry (80)</a> <a href="http://pipeline.corante.com/archives/analytical_chemistry.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/animal_testing/">Animal Testing (33)</a> <a href="http://pipeline.corante.com/archives/animal_testing.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/autism/">Autism (23)</a> <a href="http://pipeline.corante.com/archives/autism.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/biological_news/">Biological News (233)</a> <a href="http://pipeline.corante.com/archives/biological_news.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/birth_of_an_idea/">Birth of an Idea (43)</a> <a href="http://pipeline.corante.com/archives/birth_of_an_idea.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/blink_8250/">Blink › (5)</a> <a href="http://pipeline.corante.com/archives/blink_8250.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/blog_housekeeping/">Blog Housekeeping (240)</a> <a href="http://pipeline.corante.com/archives/blog_housekeeping.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/book_recommenda/">Book Recommendations (28)</a> <a href="http://pipeline.corante.com/archives/book_recommendations.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/business_and_markets/">Business and Markets (868)</a> <a href="http://pipeline.corante.com/archives/business_and_markets.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/cancer/">Cancer (280)</a> <a href="http://pipeline.corante.com/archives/cancer.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/cardiovascular_disease/">Cardiovascular Disease (141)</a> <a href="http://pipeline.corante.com/archives/cardiovascular_disease.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/chembio_warfare/">Chem/Bio Warfare (15)</a> <a href="http://pipeline.corante.com/archives/chembio_warfare.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/chemical_biolog/">Chemical Biology (76)</a> <a href="http://pipeline.corante.com/archives/chemical_biology.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/chemical_news/">Chemical News (374)</a> <a href="http://pipeline.corante.com/archives/chemical_news.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/clinical_trials/">Clinical Trials (334)</a> <a href="http://pipeline.corante.com/archives/clinical_trials.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/closing_time/">Closing Time (17)</a> <a href="http://pipeline.corante.com/archives/closing_time.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/current_events/">Current Events (142)</a> <a href="http://pipeline.corante.com/archives/current_events.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/diabetes_and_obesity/">Diabetes and Obesity (131)</a> <a href="http://pipeline.corante.com/archives/diabetes_and_obesity.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/drug_assays/">Drug Assays (242)</a> <a href="http://pipeline.corante.com/archives/drug_assays.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/drug_development/">Drug Development (451)</a> <a href="http://pipeline.corante.com/archives/drug_development.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/drug_industry_history/">Drug Industry History (337)</a> <a href="http://pipeline.corante.com/archives/drug_industry_history.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/drug_prices/">Drug Prices (110)</a> <a href="http://pipeline.corante.com/archives/drug_prices.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/general_scientific_news/">General Scientific News (161)</a> <a href="http://pipeline.corante.com/archives/general_scientific_news.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/graduate_school/">Graduate School (62)</a> <a href="http://pipeline.corante.com/archives/graduate_school.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/how_not_to_do_it/">How Not to Do It (39)</a> <a href="http://pipeline.corante.com/archives/how_not_to_do_it.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/how_to_get_a_pharma_job/">How To Get a Pharma Job (31)</a> <a href="http://pipeline.corante.com/archives/how_to_get_a_pharma_job.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/in_silico/">In Silico (107)</a> <a href="http://pipeline.corante.com/archives/in_silico.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/infectious_diseases/">Infectious Diseases (149)</a> <a href="http://pipeline.corante.com/archives/infectious_diseases.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/inorganic_chemi/">Inorganic Chemistry (4)</a> <a href="http://pipeline.corante.com/archives/inorganic_chemistry.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/intelligent_design/">Intelligent Design (9)</a> <a href="http://pipeline.corante.com/archives/intelligent_design.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/job_postings/">Job Postings (1)</a> <a href="http://pipeline.corante.com/archives/job_postings.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/life_as_we_dont_know_it/">Life As We (Don't) Know It (23)</a> <a href="http://pipeline.corante.com/archives/life_as_we_dont_know_it.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/life_in_the_drug_labs/">Life in the Drug Labs (329)</a> <a href="http://pipeline.corante.com/archives/life_in_the_drug_labs.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/lowes_laws_of_the_lab/">Lowe's Laws of the Lab (7)</a> <a href="http://pipeline.corante.com/archives/lowes_laws_of_the_lab.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/metaphors_good/">Metaphors, Good and Bad (2)</a> <a href="http://pipeline.corante.com/archives/metaphors_good_and_bad.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/natural_product/">Natural Products (25)</a> <a href="http://pipeline.corante.com/archives/natural_products.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/odd_elements_in_drugs/">Odd Elements in Drugs (12)</a> <a href="http://pipeline.corante.com/archives/odd_elements_in_drugs.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/patents_and_ip/">Patents and IP (148)</a> <a href="http://pipeline.corante.com/archives/patents_and_ip.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/pharma_101/">Pharma 101 (14)</a> <a href="http://pipeline.corante.com/archives/pharma_101.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/pharmacokinetics/">Pharmacokinetics (56)</a> <a href="http://pipeline.corante.com/archives/pharmacokinetics.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/press_coverage/">Press Coverage (89)</a> <a href="http://pipeline.corante.com/archives/press_coverage.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/regulatory_affa/">Regulatory Affairs (168)</a> <a href="http://pipeline.corante.com/archives/regulatory_affairs.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/safety_warnings/">Safety Warnings (18)</a> <a href="http://pipeline.corante.com/archives/safety_warnings.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/science_gifts/">Science Gifts (13)</a> <a href="http://pipeline.corante.com/archives/science_gifts.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/snake_oil/">Snake Oil (85)</a> <a href="http://pipeline.corante.com/archives/snake_oil.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/the_central_nervous_system/">The Central Nervous System (131)</a> <a href="http://pipeline.corante.com/archives/the_central_nervous_system.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/the_dark_side/">The Dark Side (190)</a> <a href="http://pipeline.corante.com/archives/the_dark_side.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/the_scientific_literature/">The Scientific Literature (378)</a> <a href="http://pipeline.corante.com/archives/the_scientific_literature.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/things_i_wont_work_with/">Things I Won't Work With (30)</a> <a href="http://pipeline.corante.com/archives/things_i_wont_work_with.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/things_im_glad_i_dont_do/">Things I'm Glad I Don't Do (4)</a> <a href="http://pipeline.corante.com/archives/things_im_glad_i_dont_do.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/toxicology/">Toxicology (153)</a> <a href="http://pipeline.corante.com/archives/toxicology.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/who_discovers_and_why/">Who Discovers and Why (145)</a> <a href="http://pipeline.corante.com/archives/who_discovers_and_why.xml"><span class="catxml">[xml]</span></a><br>

› <a href="http://pipeline.corante.com/archives/why_everyone_loves_us/">Why  Everyone Loves Us (82)</a> <a href="http://pipeline.corante.com/archives/why_everyone_loves_us.xml"><span class="catxml">[xml]</span></a><br>


</div>
</div>

<div class="sidetitle">
› <a href="http://pipeline.corante.com/archives/date_index.php">ARCHIVES</a></div>
<div id="monthly">
<div class="rside">
› <a href="http://pipeline.corante.com/archives/2015/05/">May 2015 (35)</a><br>
› <a href="http://pipeline.corante.com/archives/2015/04/">April 2015 (45)</a><br>
› <a href="http://pipeline.corante.com/archives/2015/03/">March 2015 (55)</a><br>
› <a href="http://pipeline.corante.com/archives/2015/02/">February 2015 (43)</a><br>
› <a href="http://pipeline.corante.com/archives/2015/01/">January 2015 (45)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/12/">December 2014 (42)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/11/">November 2014 (44)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/10/">October 2014 (48)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/09/">September 2014 (42)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/08/">August 2014 (30)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/07/">July 2014 (40)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/06/">June 2014 (44)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/05/">May 2014 (56)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/04/">April 2014 (39)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/03/">March 2014 (45)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/02/">February 2014 (42)</a><br>
› <a href="http://pipeline.corante.com/archives/2014/01/">January 2014 (43)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/12/">December 2013 (41)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/11/">November 2013 (44)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/10/">October 2013 (50)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/09/">September 2013 (34)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/08/">August 2013 (42)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/07/">July 2013 (51)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/06/">June 2013 (39)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/05/">May 2013 (40)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/04/">April 2013 (46)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/03/">March 2013 (52)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/02/">February 2013 (45)</a><br>
› <a href="http://pipeline.corante.com/archives/2013/01/">January 2013 (50)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/12/">December 2012 (39)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/11/">November 2012 (48)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/10/">October 2012 (42)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/09/">September 2012 (49)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/08/">August 2012 (38)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/07/">July 2012 (27)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/06/">June 2012 (37)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/05/">May 2012 (47)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/04/">April 2012 (31)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/03/">March 2012 (38)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/02/">February 2012 (46)</a><br>
› <a href="http://pipeline.corante.com/archives/2012/01/">January 2012 (44)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/12/">December 2011 (35)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/11/">November 2011 (44)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/10/">October 2011 (35)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/09/">September 2011 (32)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/08/">August 2011 (37)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/07/">July 2011 (26)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/06/">June 2011 (35)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/05/">May 2011 (40)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/04/">April 2011 (31)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/03/">March 2011 (40)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/02/">February 2011 (27)</a><br>
› <a href="http://pipeline.corante.com/archives/2011/01/">January 2011 (35)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/12/">December 2010 (34)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/11/">November 2010 (28)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/10/">October 2010 (39)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/09/">September 2010 (37)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/08/">August 2010 (38)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/07/">July 2010 (30)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/06/">June 2010 (42)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/05/">May 2010 (44)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/04/">April 2010 (48)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/03/">March 2010 (63)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/02/">February 2010 (36)</a><br>
› <a href="http://pipeline.corante.com/archives/2010/01/">January 2010 (38)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/12/">December 2009 (25)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/11/">November 2009 (35)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/10/">October 2009 (30)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/09/">September 2009 (32)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/08/">August 2009 (27)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/07/">July 2009 (24)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/06/">June 2009 (40)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/05/">May 2009 (36)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/04/">April 2009 (24)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/03/">March 2009 (35)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/02/">February 2009 (33)</a><br>
› <a href="http://pipeline.corante.com/archives/2009/01/">January 2009 (32)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/12/">December 2008 (17)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/11/">November 2008 (18)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/10/">October 2008 (24)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/09/">September 2008 (22)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/08/">August 2008 (15)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/07/">July 2008 (23)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/06/">June 2008 (20)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/05/">May 2008 (20)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/04/">April 2008 (22)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/03/">March 2008 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/02/">February 2008 (20)</a><br>
› <a href="http://pipeline.corante.com/archives/2008/01/">January 2008 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/12/">December 2007 (15)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/11/">November 2007 (23)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/10/">October 2007 (23)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/09/">September 2007 (19)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/08/">August 2007 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/07/">July 2007 (17)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/06/">June 2007 (12)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/05/">May 2007 (19)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/04/">April 2007 (23)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/03/">March 2007 (19)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/02/">February 2007 (27)</a><br>
› <a href="http://pipeline.corante.com/archives/2007/01/">January 2007 (23)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/12/">December 2006 (16)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/11/">November 2006 (20)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/10/">October 2006 (24)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/09/">September 2006 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/08/">August 2006 (19)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/07/">July 2006 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/06/">June 2006 (24)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/05/">May 2006 (27)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/04/">April 2006 (20)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/03/">March 2006 (27)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/02/">February 2006 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2006/01/">January 2006 (24)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/12/">December 2005 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/11/">November 2005 (25)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/10/">October 2005 (26)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/09/">September 2005 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/08/">August 2005 (29)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/07/">July 2005 (18)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/06/">June 2005 (24)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/05/">May 2005 (22)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/04/">April 2005 (18)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/03/">March 2005 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/02/">February 2005 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2005/01/">January 2005 (24)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/12/">December 2004 (24)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/11/">November 2004 (20)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/10/">October 2004 (23)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/09/">September 2004 (18)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/08/">August 2004 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/07/">July 2004 (15)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/06/">June 2004 (19)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/05/">May 2004 (20)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/04/">April 2004 (20)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/03/">March 2004 (20)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/02/">February 2004 (23)</a><br>
› <a href="http://pipeline.corante.com/archives/2004/01/">January 2004 (18)</a><br>
› <a href="http://pipeline.corante.com/archives/2003/12/">December 2003 (1)</a><br>
› <a href="http://pipeline.corante.com/archives/2003/11/">November 2003 (1)</a><br>
› <a href="http://pipeline.corante.com/archives/2003/08/">August 2003 (1)</a><br>
› <a href="http://pipeline.corante.com/archives/2003/01/">January 2003 (9)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/12/">December 2002 (24)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/11/">November 2002 (19)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/10/">October 2002 (26)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/09/">September 2002 (18)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/08/">August 2002 (18)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/07/">July 2002 (21)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/06/">June 2002 (12)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/05/">May 2002 (18)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/04/">April 2002 (9)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/03/">March 2002 (7)</a><br>
› <a href="http://pipeline.corante.com/archives/2002/02/">February 2002 (14)</a><br>

</div>
</div>
</div>


</div>
<br>
<br>
<a href="http://feeds.feedburner.com/InThePipeline"><img src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/xml2.gif" border="0"></a> 
<br>
<a href="http://feeds.feedburner.com/InThePipeline">
<img src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/sub_modern5.gif" alt="Subscribe with Bloglines" border="0">
</a>



<!-- Start of StatCounter Code for Default Guide -->
<script type="text/javascript">
var sc_project=9776108; 
var sc_invisible=1; 
var sc_security="a99e4709"; 
var scJsHost = (("https:" == document.location.protocol) ?
"https://secure." : "http://www.");
document.write("<sc"+"ript type='text/javascript' src='" +
scJsHost+
"statcounter.com/counter/counter.js'></"+"script>");
</script><script type="text/javascript" src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/counter.js"></script>
<noscript><div class="statcounter"><a title="website
statistics" href="http://statcounter.com/"
target="_blank"><img class="statcounter"
src="http://c.statcounter.com/9776108/0/a99e4709/1/"
alt="website statistics"></a></div></noscript>
<!-- End of StatCounter Code for Default Guide --></td>
</tr>
</tbody></table>
</td>
</tr>
<tr>
<td colspan="3">
<table id="footerbend" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr>
<td height="9"><img style="float:right;margin-right:-3px" src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/footer_bottom_blue_t.gif" alt="" border="0"></td>
</tr>
<tr>
<td id="footer" colspan="2" height="140">
<p>
<a href="http://www.corante.com/about.php">About Us</a> | 
<a href="http://www.corante.com/adinfo.php">Advertise</a> | 
<a href="http://www.corante.com/contact.php">Contact Us</a> | 
</p>
<p>
<a href="http://www.corante.com/privacy.php">Privacy Policy</a> | 
<a href="http://www.corante.com/terms.php">Terms of Use</a>
</p>
<p>© Copyright 2006 Corante. All rights reserved. ()</p>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<!-- Resonance code resxclsa.js v2.x Copyright 2004-2006 Certona Corporation www.certona.com -->
<script language="JavaScript">
<!--
var resx = new Object();
resx.appid="corante01";
resx.top1=100000;
resx.top2=100000;
resx.lkmatch=/\/archives\/\d+\/\S+/i;
resx.rrec=false;
//-->
</script>
<script language="JavaScript" src="Drug%20Assay%20Numbers,%20All%20Over%20the%20Place.%20In%20the%20Pipeline__files/resxclsa.html"></script>
<!-- Resonance -->



</td></tr></tbody></table></body></html>